WIN-68210

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameWIN-68210
Drug Alias NameSW-68210
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi-Synthelabo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Synthelabo
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A